Article
Bifidobacterium in anticancer immunochemotherapy: friend or foe?
10 Jul 2023
Abstract excerpt
The gut microbiome has received a crescendo of attention in recent years due to myriad influences on human pathophysiology, including cancer. Anticancer therapy research is constantly looking for new hints to improve response to therapy while reducing the risk of relapse. In this scenario, Bifidobacterium, which inhabits the gut microbial ecosystem (especially that of children) and is considered a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
